Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
47 studies found for:    Open Studies | "Ocular Motility Disorders"
Show Display Options
Rank Status Study
21 Recruiting Dichoptic Virtual Reality Therapy for Amblyopia in Adults
Conditions: Amblyopia;   Anisometropia;   Strabismus
Interventions: Device: Dichoptic therapy;   Other: Patching therapy;   Device: Dioptic (non-dichoptic) therapy
22 Recruiting Neurovascular Coupling in Subjects With Amblyopia
Conditions: Amblyopia ex Strabismus;   Amblyopia ex Anisometropia
Interventions: Device: Dynamic Vessel Analyzer;   Other: Laser Doppler Velocimetry;   Device: 7-Tesla MRI;   Other: Pattern electroretinography;   Other: Fourier domain optical coherence tomography
23 Recruiting Factors Associated With Postoperative Strabismus After Floor Fracture Repair
Conditions: Orbital Fractures;   Strabismus
Intervention: Procedure: Floor repair surgery
24 Recruiting Effect of Remifentanil on Postoperative Vomiting in Pediatric Strabismus Surgery
Condition: Strabismus
Interventions: Drug: High dose remifentanil;   Drug: Low dose remifentanil;   Drug: No remifentanil
25 Recruiting Utility of a Survey Instrument to Predict Benefit From a Novel Treatment for Vertical Heterophoria
Conditions: Binocular Vision Dysfunction;   Vertical Heterophoria
Intervention: Other: Questionnaires and Optometrist Prism Challenge/Treatment
26 Recruiting 4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2
Conditions: Corticobasal Degeneration (CBD);   Corticobasal Syndrome (CBS);   Cortical-basal Ganglionic Degeneration (CBGD);   Progressive Supranuclear Palsy (PSP);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   Oligosymptomatic/Variant Progressive Supranuclear Palsy (o/vPSP)
Intervention: Other: Observational Study
27 Recruiting Diagnosing Frontotemporal Lobar Degeneration
Conditions: Corticobasal Syndrome;   Progressive Supranuclear Palsy;   Behavioral Variant Frontotemporal Dementia;   Semantic Dementia;   Progressive Nonfluent Aphasia;   Amyotrophic Lateral Sclerosis and/or Frontotemporal Dementia
Intervention: Other: Observational Study
28 Recruiting Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy (PSP)
Interventions: Drug: Rivastigmine;   Drug: Placebo
29 Recruiting PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK
Conditions: Progressive Supranuclear Palsy (PSP);   Corticobasal Degeneration;   Multiple System Atrophy (MSA)
Intervention:
30 Not yet recruiting Unique Brainstem Biomarkers of Early Parkinson's Disease
Conditions: Parkinson's Disease;   Alzheimer's Disease;   Progressive Supranuclear Palsy;   Essential Tremor;   Multiple System Atrophy;   Drug Induced Parkinson's Disease;   Diffuse Lewy Body Disease;   Myasthenia Gravis
Interventions: Other: Electrical Brainstem Responses;   Other: Olfactory Tests;   Other: Visual Deprivation
31 Recruiting A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy
Intervention: Drug: F-18 AV 1451
32 Recruiting Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies
Conditions: Alzheimer's Disease (AD);   Progressive Supranuclear Palsy (PSP);   Cortical Basal Syndrome (CBS);   Frontal Temporal Dementia (FTD)
Intervention: Drug: [18F]MNI-815 (MNI-815)
33 Recruiting Young Plasma Transfusions for Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy
Intervention: Other: Fresh Frozen Plasma
34 Recruiting Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Syndromes
Conditions: Parkinson's Disease;   Multiple System Atrophy;   Progressive Supranuclear Palsy;   Vascular Parkinsonism
Intervention: Other: MRI exam of the brain
35 Recruiting Inherited Retinal Degenerative Disease Registry
Conditions: Eye Diseases Hereditary;   Retinal Disease;   Achromatopsia;   Bardet-Biedl Syndrome;   Bassen-Kornzweig Syndrome;   Batten Disease;   Best Disease;   Choroidal Dystrophy;   Choroideremia;   Cone Dystrophy;   Cone-Rod Dystrophy;   Congenital Stationary Night Blindness;   Enhanced S-Cone Syndrome;   Fundus Albipunctatus;   Goldmann-Favre Syndrome;   Gyrate Atrophy;   Juvenile Macular Degeneration;   Kearns-Sayre Syndrome;   Leber Congenital Amaurosis;   Refsum Syndrome;   Retinitis Pigmentosa;   Retinitis Punctata Albescens;   Retinoschisis;   Rod-Cone Dystrophy;   Rod Dystrophy;   Rod Monochromacy;   Stargardt Disease;   Usher Syndrome
Intervention:
36 Recruiting A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy
Intervention: Drug: Salsalate
37 Recruiting Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
Conditions: FTLD;   Progressive Supranuclear Palsy (PSP);   Frontotemporal Dementia (FTD);   Corticobasal Degeneration (CBD);   PPA Syndrome;   Behavioral Variant Frontotemporal Dementia (bvFTD);   Semantic Variant Primary Progressive Aphasia (svPPA);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   FTD With Amyotrophic Lateral Sclerosis (FTD/ALS);   Amyotrophic Lateral Sclerosis (ALS);   Oligosymptomatic PSP (oPSP);   Corticobasal Syndrome (CBS)
Intervention:
38 Recruiting Study of the Neural Basis of Analogical Reasoning
Conditions: Frontotemporal Dementia;   Progressive Supranuclear Palsy;   Healthy Subjects
Interventions: Device: transcranial magnetic stimulation;   Other: MRI imaging;   Other: EEG recording;   Behavioral: Neuropsychological examination
39 Available Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenic Syndrome (CMS), or Downbeat Nystagmus Patients
Conditions: Lambert-Eaton Myasthenic Syndrome;   Congenital Myasthenic Syndrome;   Downbeat Nystagmus
Intervention: Drug: Amifampridine Phosphate
40 Recruiting Safety Study of TPI-287 to Treat CBS and PSP
Conditions: Primary Four Repeat Tauopathies (4RT);   Corticobasal Syndrome (CBS);   Progressive Supranuclear Palsy (PSP);   Corticobasal Degeneration (CBD)
Interventions: Drug: TPI 287 2 mg/m2;   Drug: TPI-287 20 mg/m2;   Drug: Placebo;   Drug: TPI-287 6.3 mg/m2

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-47) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.